Stemmer PM et al. |
Factors responsible for the Ca(2+)-dependent inactivation of calcineurin in brain. |
1995 |
FEBS Lett. |
pmid:7589543
|
Asano K et al. |
Generation of effector T cells in Hymenolepis nana-infected, FK-506-treated BALB/c mice. |
1995 |
Immunol. Lett. |
pmid:7590919
|
Lam E et al. |
A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. |
1995 |
J. Biol. Chem. |
pmid:7592869
|
Lee KK et al. |
Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function. |
1993 |
Am. J. Surg. |
pmid:7678188
|
Galvin F et al. |
Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen. |
1993 |
Eur. J. Immunol. |
pmid:7678228
|
Foxwell BM et al. |
Inhibition of activation-induced changes in the structure of the T cell interleukin-7 receptor by cyclosporin A and FK506. |
1993 |
Eur. J. Immunol. |
pmid:7678231
|
Hirai T et al. |
Prolonged lung allograft survival with a short course of FK 506. |
1993 |
J. Thorac. Cardiovasc. Surg. |
pmid:7678313
|
Ibarra F et al. |
Bidirectional regulation of Na+,K(+)-ATPase activity by dopamine and an alpha-adrenergic agonist. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7678337
|
Murase N et al. |
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. |
1993 |
Transplantation |
pmid:7678353
|
Herold KC et al. |
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. |
1993 |
Transplantation |
pmid:7678356
|
Holman MJ et al. |
FK506-associated thrombotic thrombocytopenic purpura. |
1993 |
Transplantation |
pmid:7678357
|
Kawai M et al. |
Structure-activity profiles of macrolactam immunosuppressant FK-506 analogues. |
1993 |
FEBS Lett. |
pmid:7678400
|
Van Duyne GD et al. |
Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. |
1993 |
J. Mol. Biol. |
pmid:7678431
|
Meadows RP et al. |
Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. |
1993 |
Biochemistry |
pmid:7678499
|
Jiang H et al. |
Anti-tumor-promoting action of FK506, a potent immunosuppressive agent. |
1993 |
Carcinogenesis |
pmid:7678785
|
Naito M et al. |
Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance. |
1993 |
J. Natl. Cancer Inst. |
pmid:7678867
|
Barthelmess IB and Tropschug M |
FK506-binding protein of Neurospora crassa (NcFKBP) mediates sensitivity to the immunosuppressant FK506; resistant mutants identify two loci. |
1993 |
Curr. Genet. |
pmid:7679056
|
Fingar DC et al. |
Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes. |
1993 |
J. Biol. Chem. |
pmid:7679106
|
McCaffrey PG et al. |
NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. |
1993 |
J. Biol. Chem. |
pmid:7679116
|
Armitage JM et al. |
Pediatric lung transplantation. The years 1985 to 1992 and the clinical trial of FK 506. |
1993 |
J. Thorac. Cardiovasc. Surg. |
pmid:7679172
|
Ito K and Komatsu Y |
[Drug induced hemolytic uremic syndrome]. |
1993 |
Nippon Rinsho |
pmid:7679450
|
Langrehr JM et al. |
Clinical course, morphology, and treatment of chronically rejecting small bowel allografts. |
1993 |
Transplantation |
pmid:7679526
|
Uemoto S et al. |
Experience with FK506 in living-related liver transplantation. |
1993 |
Transplantation |
pmid:7679528
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|
Doi R et al. |
Biochemical characterization of the effects of FK506 on signal transduction in exocytotic function of rat pancreatic acini. |
1993 |
J. Pharmacol. Exp. Ther. |
pmid:7679738
|
Cavaillé-Coll M and Mielach FA |
Choice of cyclophosphamide dose in baboon-to-human liver transplantation. |
1993 |
Lancet |
pmid:7679768
|
Hirasé Y et al. |
Transplantation of long-term cryopreserved allocutaneous tissue by skin graft or microsurgical anastomosis: experimental studies in the rat. |
1993 |
Plast. Reconstr. Surg. |
pmid:7679796
|
Kobayashi M et al. |
HLA-DR matching effect in orthotopic liver transplantation under FK 506. |
1993 |
Transplant. Proc. |
pmid:7679812
|
Watanabe K et al. |
Fate of long-surviving allografts in tolerant recipients induced by fractionated lymphoid irradiation, donor bone marrow cell infusion, and FK 506 after retransplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679813
|
Valdivia LA et al. |
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. |
1993 |
Transplant. Proc. |
pmid:7679816
|
Murase N et al. |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. |
1993 |
Transplant. Proc. |
pmid:7679817
|
Schreier MH et al. |
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? |
1993 |
Transplant. Proc. |
pmid:7679818
|
Kahan BD |
Cyclosporine: the base for immunosuppressive therapy--present and future. |
1993 |
Transplant. Proc. |
pmid:7679819
|
Starzl TE |
FK 506 versus cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679820
|
Nakajima K et al. |
Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679821
|
Tzakis AG et al. |
Two-year experience with FK 506 in pediatric patients. |
1993 |
Transplant. Proc. |
pmid:7679822
|
Gibbs JF et al. |
Outcome analysis of FK 506 therapy for acute and chronic rejection. |
1993 |
Transplant. Proc. |
pmid:7679823
|
|
Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group. |
1993 |
Transplant. Proc. |
pmid:7679824
|
Alessiani M et al. |
Adverse effects of FK 506 overdosage after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7679825
|
Klintmalm GB et al. |
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679826
|
Jordan ML et al. |
FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679827
|
Klintmalm GB et al. |
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679828
|
Lane BC et al. |
Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679829
|
Celli S et al. |
Long-term survival of heart and liver xenografts with splenectomy and FK 506. |
1993 |
Transplant. Proc. |
pmid:7679830
|
|
Japanese study of FK 506 on kidney transplantation: results of late phase II study. |
1993 |
Transplant. Proc. |
pmid:7679831
|
Kobayashi M et al. |
Production of monoclonal antibody against recombinant human FKBP-12 and subcellular localization of FKBP-12 in human mononuclear and polymorphonuclear cells. |
1993 |
Transplant. Proc. |
pmid:7679832
|
Kuroki H et al. |
Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival. |
1993 |
Transplant. Proc. |
pmid:7679833
|
Azhderian EM et al. |
Nucleus associated FK 506 binding proteins with potential relevance to FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679834
|
Porayko MK et al. |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7679835
|
Shapiro R et al. |
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. |
1993 |
Transplant. Proc. |
pmid:7679836
|
Propper DJ et al. |
Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens. |
1993 |
Transplant. Proc. |
pmid:7679837
|
Stock PG et al. |
Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: a comparison of early nephrotoxicity. |
1993 |
Transplant. Proc. |
pmid:7679838
|
Tabasco-Minguillan J et al. |
Long-term insulin requirement after liver transplantation with FK 506 in American veterans. |
1993 |
Transplant. Proc. |
pmid:7679839
|
Klintmalm GB et al. |
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679840
|
Gunji Y et al. |
Pathologic characteristics of vasculitis in renal transplant recipient dogs receiving immunosuppressive agents, FK 506, rapamycin, or RS-61443. |
1993 |
Transplant. Proc. |
pmid:7679841
|
Gregory CR et al. |
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. |
1993 |
Transplant. Proc. |
pmid:7679842
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. |
1993 |
Transplant. Proc. |
pmid:7679843
|
Inoue T et al. |
Isolation of mitochondrial cyclophilin from bovine heart. |
1993 |
Biochem. Biophys. Res. Commun. |
pmid:7679902
|
Stephens J et al. |
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. |
1993 |
Transplant. Proc. |
pmid:7680144
|
Bonet H et al. |
Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. |
1993 |
Transplant. Proc. |
pmid:7680145
|
Fung J et al. |
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7680146
|
Shibata T et al. |
Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? |
1993 |
Transplant. Proc. |
pmid:7680147
|
Todo S et al. |
Intestinal transplantation in humans under FK 506. |
1993 |
Transplant. Proc. |
pmid:7680148
|
Reyes J et al. |
Nutritional management of intestinal transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7680149
|
Abu-Elmagd KM et al. |
Monitoring and treatment of intestinal allograft rejection in humans. |
1993 |
Transplant. Proc. |
pmid:7680150
|
McCauley J et al. |
FK 506 in the management of nephrotic syndrome after renal transplantation. |
1993 |
Transplant. Proc. |
pmid:7680154
|
Mañez R et al. |
Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7680170
|
Woan MC et al. |
Characterization of the biopsy growth assay in monitoring cardiac transplant patients for rejection. |
1993 |
Transplant. Proc. |
pmid:7680171
|
Rilo HR et al. |
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. |
1993 |
Transplant. Proc. |
pmid:7680172
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. |
1993 |
Transplant. Proc. |
pmid:7680173
|
Schweizer M et al. |
Sensitivity of mitochondrial peptidyl-prolyl cis-trans isomerase, pyridine nucleotide hydrolysis and Ca2+ release to cyclosporine A and related compounds. |
1993 |
Biochem. Pharmacol. |
pmid:7680201
|
Hirao A et al. |
Effects of immunosuppressants, FK506, deoxyspergualin, and cyclosporine A on immature human hematopoiesis. |
1993 |
Blood |
pmid:7680241
|
Tamura K et al. |
Suppression of autoimmune thyroid disease by FK 506: influence on thyroid-infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. |
1993 |
Clin. Exp. Immunol. |
pmid:7680293
|
Armitage JM et al. |
A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. |
1993 |
J. Thorac. Cardiovasc. Surg. |
pmid:7680396
|
Randhawa PS et al. |
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. |
1993 |
Am. J. Surg. Pathol. |
pmid:7680544
|
Xu RX et al. |
Heteronuclear 3D NMR studies of water bound to an FK506 binding protein/immunosuppressant complex. |
1993 |
Biochemistry |
pmid:7680570
|
Egan DA et al. |
Equilibrium denaturation of recombinant human FK binding protein in urea. |
1993 |
Biochemistry |
pmid:7680574
|
Lionetti P et al. |
Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. |
1993 |
Eur. J. Immunol. |
pmid:7680613
|
Nelson PA et al. |
Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. |
1993 |
J. Immunol. |
pmid:7680683
|
Piekoszewski W and Jusko WJ |
Plasma protein binding of tacrolimus in humans. |
1993 |
J Pharm Sci |
pmid:7680714
|
Ning YM and Sánchez ER |
Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin. |
1993 |
J. Biol. Chem. |
pmid:7681058
|
Saeki T et al. |
Human P-glycoprotein transports cyclosporin A and FK506. |
1993 |
J. Biol. Chem. |
pmid:7681059
|
Dutz JP et al. |
A role for calcineurin in degranulation of murine cytotoxic T lymphocytes. |
1993 |
J. Immunol. |
pmid:7681074
|
Takeguchi N et al. |
Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7681229
|
Valdivia LA et al. |
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. |
1993 |
Transplantation |
pmid:7681230
|
Fujimura A et al. |
Chronopharmacokinetic study of a new immunosuppressive agent, FK 506, in mice. |
1993 |
Jpn. J. Pharmacol. |
pmid:7681489
|
Nishinaka Y et al. |
Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart. |
1993 |
J. Cardiovasc. Pharmacol. |
pmid:7681507
|
Luan S et al. |
Immunosuppressants implicate protein phosphatase regulation of K+ channels in guard cells. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7681590
|
Doi R et al. |
Structural and functional changes of exocrine pancreas induced by FK506 in rats. |
1993 |
Gastroenterology |
pmid:7681795
|
Rotonda J et al. |
Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis. |
1993 |
J. Biol. Chem. |
pmid:7681823
|
Xu RX et al. |
1H, 13C, and 15N assignments and secondary structure of the FK506 binding protein when bound to ascomycin. |
1993 |
Biopolymers |
pmid:7682113
|
Tanaka N et al. |
Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506. |
1993 |
Int. J. Immunopharmacol. |
pmid:7682200
|
Bruserud O and Pawelec G |
Cyclosporine A and FK506 show similar immunosuppressive effects on long-term in vitro T-cell proliferation. |
1993 |
Int. J. Immunopharmacol. |
pmid:7682202
|
Winkler M et al. |
Anaemia associated with FK 506 immunosuppression. |
1993 |
Lancet |
pmid:7682273
|
Lundemose AG et al. |
Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. |
1993 |
Mol. Microbiol. |
pmid:7682281
|
Wiesner RH et al. |
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. |
1993 |
Transplant. Proc. |
pmid:7682352
|
Frank B et al. |
Neurotoxicity of FK 506 in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7682355
|
Klintmalm GB et al. |
Rejection: FK 506 for rescue or maintenance. |
1993 |
Transplant. Proc. |
pmid:7682356
|
Woodle ES et al. |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. |
1993 |
Transplant. Proc. |
pmid:7682358
|
Woodle ES et al. |
FK 506 rescue therapy: early conversion improves efficacy. |
1993 |
Transplant. Proc. |
pmid:7682359
|